TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT04912323: The R3 Vascular Drug-Eluting Bioresorbable Scaffold in Below the Knee Vessels Trial (RESOLV I)

Sponsor: R3 Vascular Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 30 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$5,544,400

Rescue Site Savings

+$3,652,000

Unlock Full NCT04912323 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04912323 Rescue Dossier →